Healthcare Realty Trust (HR) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
27 Dec, 2025Executive summary
Reported net loss attributable to common stockholders of $(44.9) million, or $(0.13) per diluted share for Q1 2025, with normalized FFO per share at $0.39 and a declared quarterly dividend of $0.31 per share.
Peter A. Scott appointed President & CEO effective April 15, 2025, outlining a strategic plan focused on leasing, portfolio optimization, deleveraging, efficiency, and financial discipline.
The company remains a leading pure-play outpatient medical REIT with a high-quality portfolio in high-growth markets and strong tenant relationships.
351.4M shares of common stock were outstanding as of April 25, 2025.
Company operates as a single segment, managing 34.3M sq. ft. with 92% self-managed properties.
Financial highlights
Total revenues for Q1 2025 were $298.98 million, down from $309.77 million in Q4 2024 and $326.81 million in Q1 2024, primarily due to property dispositions.
Normalized FFO was $137.7 million, or $0.39 per diluted share, and FFO per share (diluted) was $0.35, up from $0.30 in Q4 2024.
Same-store cash NOI growth was 2.3% year-over-year, with NOI margin for the same-store portfolio at 62.9%.
Net loss improved from $(106.8) million in Q4 2024 to $(44.9) million in Q1 2025.
Four buildings sold for $28.1 million; $38 million loan payoff received post-quarter, totaling $66 million in gross proceeds.
Outlook and guidance
Reaffirmed 2025 normalized FFO per share guidance of $1.56–$1.60, with NAREIT FFO per share $1.44–$1.48 and EPS $(0.28)–$(0.13).
Guidance reflects assumptions on rental rates, occupancy, interest rates, and expenses, and excludes impacts from gains/losses on dispositions and impairments.
Management expects to fund 2025 dividends from operations and available liquidity, with cash flows projected to cover full-year dividends.
Sequential occupancy growth anticipated through 2025, with 75–125 basis points of absorption by year-end.
No new acquisitions in Q1 2025; focus remains on portfolio optimization and capital recycling.
Latest events from Healthcare Realty Trust
- Strong leasing, $1.2B asset sales, and improved leverage drive positive 2025 and 2026 outlook.HR
Q4 202513 Feb 2026 - Q2 net loss on impairments, but strong leasing, asset sales, and FFO guidance affirmed.HR
Q2 20242 Feb 2026 - Normalized FFO per share rose 1.2% as leasing, asset sales, and share buybacks drove activity.HR
Q3 202417 Jan 2026 - Record leasing, robust FFO growth, and deleveraging highlight 2024 performance.HR
Q4 202429 Dec 2025 - Board recommends approval of all proposals, with strong focus on pay-for-performance and ESG.HR
Proxy Filing1 Dec 2025 - Key votes include board elections, auditor ratification, and executive pay approval.HR
Proxy Filing1 Dec 2025 - Q2 2025 saw strong FFO, higher guidance, a dividend cut, and major asset sales.HR
Q2 202516 Nov 2025 - Q3 2025 saw 5% FFO growth, strong leasing, asset sales, and improved guidance despite a net loss.HR
Q3 20252 Nov 2025